• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Metal-dependent Deacetylases: Cancer and Epigenetic Regulators.金属依赖性脱乙酰酶:癌症与表观遗传调节因子
ACS Chem Biol. 2016 Mar 18;11(3):706-16. doi: 10.1021/acschembio.5b01067.
2
Histone deacetylases as targets in autoimmune and autoinflammatory diseases.组蛋白去乙酰化酶作为自身免疫和自身炎症性疾病的靶点。
Adv Immunol. 2020;147:1-59. doi: 10.1016/bs.ai.2020.06.001. Epub 2020 Jul 15.
3
Histone deacetylases and cancer.组蛋白去乙酰化酶与癌症。
Mol Oncol. 2012 Dec;6(6):579-89. doi: 10.1016/j.molonc.2012.07.003. Epub 2012 Aug 27.
4
Histone deacetylases: a saga of perturbed acetylation homeostasis in cancer.组蛋白去乙酰化酶:癌症中失调的乙酰化平衡的传奇。
J Histochem Cytochem. 2014 Jan;62(1):11-33. doi: 10.1369/0022155413506582. Epub 2013 Sep 18.
5
HDAC modulation and cell death in the clinic.组蛋白去乙酰化酶的调节与临床细胞死亡
Exp Cell Res. 2012 Jul 1;318(11):1229-44. doi: 10.1016/j.yexcr.2012.01.025. Epub 2012 Feb 3.
6
Natural Agents-Mediated Targeting of Histone Deacetylases.天然药物介导的组蛋白去乙酰化酶靶向治疗。
Arch Immunol Ther Exp (Warsz). 2018 Feb;66(1):31-44. doi: 10.1007/s00005-017-0488-0. Epub 2017 Aug 30.
7
Linking epigenetics to lipid metabolism: focus on histone deacetylases.将表观遗传学与脂质代谢联系起来:聚焦于组蛋白去乙酰化酶。
Mol Membr Biol. 2012 Nov;29(7):257-66. doi: 10.3109/09687688.2012.729094. Epub 2012 Oct 24.
8
Chemical and structural biology of protein lysine deacetylases.蛋白质赖氨酸脱乙酰酶的化学与结构生物学
Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(5):297-321. doi: 10.2183/pjab.93.019.
9
Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.表观遗传药物作为癌症治疗中的多效性药物:生物分子方面及临床应用
J Cell Physiol. 2007 Aug;212(2):330-44. doi: 10.1002/jcp.21066.
10
K-acetylation and its enzymes: overview and new developments.K-乙酰化及其相关酶:综述与新进展
Handb Exp Pharmacol. 2011;206:1-12. doi: 10.1007/978-3-642-21631-2_1.

引用本文的文献

1
Cardioprotective role of SIRT1 activation on mitochondrial function in insulin-resistant H9c2 cells.SIRT1激活对胰岛素抵抗H9c2细胞线粒体功能的心脏保护作用。
BMC Cardiovasc Disord. 2025 Mar 29;25(1):232. doi: 10.1186/s12872-024-04397-7.
2
Mechanism-Based Inhibition of Histone Deacetylase 6 by a Selenocyanate Is Subject to Redox Modulation.硒氰酸盐对组蛋白去乙酰化酶6的基于机制的抑制作用受氧化还原调节。
J Am Chem Soc. 2025 Feb 26;147(8):6373-6377. doi: 10.1021/jacs.5c00157. Epub 2025 Feb 17.
3
Mechanism-Based Inhibition of Histone Deacetylase 6 by a Selenocyanate is Subject to Redox Modulation.硒氰酸盐对组蛋白去乙酰化酶6的基于机制的抑制作用受氧化还原调节。
bioRxiv. 2025 Jan 4:2025.01.04.631333. doi: 10.1101/2025.01.04.631333.
4
Design, Synthesis, and Structural Evaluation of Acetylated Phenylthioketone Inhibitors of HDAC10.组蛋白去乙酰化酶10(HDAC10)的乙酰化苯硫酮抑制剂的设计、合成及结构评估
ACS Med Chem Lett. 2024 Sep 5;15(10):1715-1723. doi: 10.1021/acsmedchemlett.4c00293. eCollection 2024 Oct 10.
5
Role of protein Post-translational modifications in enterovirus infection.蛋白质翻译后修饰在肠道病毒感染中的作用。
Front Microbiol. 2024 Feb 26;15:1341599. doi: 10.3389/fmicb.2024.1341599. eCollection 2024.
6
Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs).基于结构的 I 类组蛋白去乙酰化酶(HDACs)抑制剂发现。
Int J Mol Sci. 2020 Nov 22;21(22):8828. doi: 10.3390/ijms21228828.
7
Binding of inhibitors to active-site mutants of CD1, the enigmatic catalytic domain of histone deacetylase 6.抑制剂与组蛋白去乙酰化酶 6 神秘催化结构域 CD1 的活性位点突变体的结合。
Acta Crystallogr F Struct Biol Commun. 2020 Sep 1;76(Pt 9):428-437. doi: 10.1107/S2053230X20010250. Epub 2020 Aug 19.
8
Structural determinants of affinity and selectivity in the binding of inhibitors to histone deacetylase 6.抑制剂与组蛋白去乙酰化酶 6 结合的亲和力和选择性的结构决定因素。
Bioorg Med Chem Lett. 2020 Apr 15;30(8):127023. doi: 10.1016/j.bmcl.2020.127023. Epub 2020 Feb 11.
9
Exploring Structural Determinants of Inhibitor Affinity and Selectivity in Complexes with Histone Deacetylase 6.探究组蛋白去乙酰化酶 6 复合物中抑制剂亲和力和选择性的结构决定因素。
J Med Chem. 2020 Jan 9;63(1):295-308. doi: 10.1021/acs.jmedchem.9b01540. Epub 2019 Dec 19.
10
Structural Basis of Catalysis and Inhibition of HDAC6 CD1, the Enigmatic Catalytic Domain of Histone Deacetylase 6.结构基础的催化和抑制 hDAC6 CD1 ,神秘的催化结构域的组蛋白脱乙酰酶 6 。
Biochemistry. 2019 Dec 10;58(49):4912-4924. doi: 10.1021/acs.biochem.9b00934. Epub 2019 Dec 2.

本文引用的文献

1
General Base-General Acid Catalysis in Human Histone Deacetylase 8.人类组蛋白去乙酰化酶8中的一般碱-一般酸催化作用
Biochemistry. 2016 Feb 9;55(5):820-32. doi: 10.1021/acs.biochem.5b01327. Epub 2016 Jan 25.
2
Histone deacetylase 6 inhibition enhances oncolytic viral replication in glioma.组蛋白去乙酰化酶6抑制作用增强了溶瘤病毒在胶质瘤中的复制。
J Clin Invest. 2015 Nov 2;125(11):4269-80. doi: 10.1172/JCI80713. Epub 2015 Oct 20.
3
Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy.黑色素瘤对靶向治疗和免疫治疗耐药中的组蛋白修饰、修饰酶及识别蛋白
Cancers (Basel). 2015 Sep 25;7(4):1959-82. doi: 10.3390/cancers7040870.
4
Regulation of Histone Deacetylase 6 Activity via S-Nitrosylation.通过S-亚硝基化对组蛋白去乙酰化酶6活性的调控
Biol Pharm Bull. 2015;38(9):1434-7. doi: 10.1248/bpb.b15-00364.
5
FDA approves new agent for multiple myeloma.美国食品药品监督管理局批准用于多发性骨髓瘤的新药物。
J Natl Cancer Inst. 2015 Jun 1;107(6):djv165. doi: 10.1093/jnci/djv165. Print 2015 Jun.
6
Histone deacetylase inhibitors prevent activation-induced cell death and promote anti-tumor immunity.组蛋白去乙酰化酶抑制剂可预防活化诱导的细胞死亡并促进抗肿瘤免疫。
Oncogene. 2015 Dec 3;34(49):5960-70. doi: 10.1038/onc.2015.46. Epub 2015 Mar 9.
7
Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents.作为新型抗癌药物模板的临床研究中的组蛋白去乙酰化酶抑制剂
Molecules. 2015 Mar 2;20(3):3898-941. doi: 10.3390/molecules20033898.
8
Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation.对组蛋白去乙酰化酶8(HDAC8)的选择性抑制可在体外和体内降低神经母细胞瘤的生长,并增强视黄酸介导的分化。
Cell Death Dis. 2015 Feb 19;6(2):e1657. doi: 10.1038/cddis.2015.24.
9
50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond.50 年的蛋白质乙酰化研究:从基因调控到表观遗传学、代谢及其他领域。
Nat Rev Mol Cell Biol. 2015 Apr;16(4):258-64. doi: 10.1038/nrm3931. Epub 2014 Dec 30.
10
HDAC inhibition imparts beneficial transgenerational effects in Huntington's disease mice via altered DNA and histone methylation.组蛋白去乙酰化酶抑制通过改变DNA和组蛋白甲基化,对亨廷顿舞蹈病小鼠产生有益的跨代效应。
Proc Natl Acad Sci U S A. 2015 Jan 6;112(1):E56-64. doi: 10.1073/pnas.1415195112. Epub 2014 Dec 22.

金属依赖性脱乙酰酶:癌症与表观遗传调节因子

Metal-dependent Deacetylases: Cancer and Epigenetic Regulators.

作者信息

López Jeffrey E, Sullivan Eric D, Fierke Carol A

机构信息

Interdepartmental Program in Chemical Biology, University of Michigan , 210 Washtenaw Avenue, Ann Arbor, Michigan 48109-2216, United States.

Departments of Chemistry and Biological Chemistry, University of Michigan , 930 North University Avenue, Ann Arbor, Michigan 48109-2216, United States.

出版信息

ACS Chem Biol. 2016 Mar 18;11(3):706-16. doi: 10.1021/acschembio.5b01067.

DOI:10.1021/acschembio.5b01067
PMID:26907466
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5590829/
Abstract

Epigenetic regulation is a key factor in cellular homeostasis. Post-translational modifications (PTMs) are a central focus of this regulation as they function as signaling markers within the cell. Lysine acetylation is a dynamic, reversible PTM that has garnered recent attention due to alterations in various types of cancer. Acetylation levels are regulated by two opposing enzyme families: lysine acetyltransferases (KATs) and histone deacetylases (HDACs). HDACs are key players in epigenetic regulation and have a role in the silencing of tumor suppressor genes. The dynamic equilibrium of acetylation makes HDACs attractive targets for drug therapy. However, substrate selectivity and biological function of HDAC isozymes is poorly understood. This review outlines the current understanding of the roles and specific epigenetic interactions of the metal-dependent HDACs in addition to their roles in cancer.

摘要

表观遗传调控是细胞稳态的关键因素。翻译后修饰(PTMs)是这种调控的核心焦点,因为它们在细胞内充当信号标记。赖氨酸乙酰化是一种动态、可逆的PTM,由于其在各种癌症中的改变,最近受到了关注。乙酰化水平由两个相互对立的酶家族调节:赖氨酸乙酰转移酶(KATs)和组蛋白脱乙酰酶(HDACs)。HDACs是表观遗传调控的关键参与者,在肿瘤抑制基因的沉默中发挥作用。乙酰化的动态平衡使HDACs成为药物治疗的有吸引力的靶点。然而,HDAC同工酶的底物选择性和生物学功能了解甚少。本综述概述了目前对金属依赖性HDACs的作用、特定表观遗传相互作用及其在癌症中的作用的理解。